Andrea Messori

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 226 publications

Trastuzumab deruxtecan plus pertuzumab as a substantial advancement in previously untreated patients with HER2-positive metastatic breast cancer.

Trastuzumab deruxtecan plus pertuzumab as a substantial advancement in previously untreated patients with HER2-positive metastatic breast cancer.

Journal: European review for medical and pharmacological sciences

Published: September 01, 2026

Comments on: Use of artificial intelligence to draft a mini-HTA report on a new medical device belonging to class IIb-III.

Comments on: Use of artificial intelligence to draft a mini-HTA report on a new medical device belonging to class IIb-III.

Journal: Global & regional health technology assessment

Published: June 17, 2026

Pirtobrutinib Monotherapy for First-Line Chronic Lymphocytic Leukemia: A Non-Anchored Indirect Comparison Using Reconstructed Patient-Level Data.

Pirtobrutinib Monotherapy for First-Line Chronic Lymphocytic Leukemia: A Non-Anchored Indirect Comparison Using Reconstructed Patient-Level Data.

Journal: Hematology reports

Published: May 13, 2026

Comparative Efficacy of First-Line Therapeutic Options for ES-SCLC: An Indirect Comparison Using IPDfromKM-Reconstructed Individual Patient Data.

Comparative Efficacy of First-Line Therapeutic Options for ES-SCLC: An Indirect Comparison Using IPDfromKM-Reconstructed Individual Patient Data.

Journal: Cancers

Published: May 07, 2026

Correction: Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials.

Correction: Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials.

Journal: Cureus

Published: March 09, 2026

Survival in unresectable hepatocellular carcinoma: Comparison of four treatments based on patients reconstructed from Kaplan-Meier curves of randomized trials.

Survival in unresectable hepatocellular carcinoma: Comparison of four treatments based on patients reconstructed from Kaplan-Meier curves of randomized trials.

Journal: World journal of gastrointestinal pharmacology and therapeutics

Published: February 27, 2026

Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials.

Sotatercept Versus Selexipag in Severe Pulmonary Arterial Hypertension: An Indirect Comparison of Efficacy Based on an Artificial-Intelligence Method That Reconstructed Patient-Level Data From Three Randomized Trials.

Journal: Cureus

Published: February 19, 2026

Effectiveness of patent foramen ovale occlusion devices versus medical therapy: An indirect comparison based on reconstructed individual patient data.

Effectiveness of patent foramen ovale occlusion devices versus medical therapy: An indirect comparison based on reconstructed individual patient data.

Journal: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

Published: January 14, 2026

Updating Efficacy of First-Line Treatments for Chronic Lymphocytic Leukemia: Indirect Comparisons Based on Recent Data Favor the Combination of Acalabrutinib Plus Obinutuzumab.

Updating Efficacy of First-Line Treatments for Chronic Lymphocytic Leukemia: Indirect Comparisons Based on Recent Data Favor the Combination of Acalabrutinib Plus Obinutuzumab.

Journal: European journal of haematology

Published: December 26, 2025

Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data.

Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed Data.

Journal: Oncology research

Published: December 15, 2025

Use of artificial intelligence to draft a mini-HTA report on a new medical device belonging to class IIb-III.

Use of artificial intelligence to draft a mini-HTA report on a new medical device belonging to class IIb-III.

Journal: Global & regional health technology assessment

Published: November 27, 2025

Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based Regimens.

Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based Regimens.

Journal: Cancers

Published: September 24, 2025

Showing 1-12 of 226

Last Updated: 09/26/2026